ENTRY       D08095                      Drug
NAME        Ivabradine hydrochloride (JAN/USAN);
            Ivabrandine hydrochloride;
            Corlanor (TN);
            Corlentor (TN);
            Coralan (TN)
PRODUCT     CORLANOR (Amgen)
            CORLANOR (REMEDYREPACK)
FORMULA     C27H36N2O5. HCl
EXACT_MASS  504.2391
MOL_WEIGHT  505.0461
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2190
            ATC code: C01EB17
            Chemical structure group: DG00246
            Product (DG00246): D08095<JP/US>
EFFICACY    Cardiotonic, HCN channel blocker
TARGET      HCN [HSA:348980 610 57657 10021] [KO:K04954 K04955 K04956 K04957]
  PATHWAY   hsa04024(10021+610)  cAMP signaling pathway
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01E OTHER CARDIAC PREPARATIONS
                C01EB Other cardiac preparations
                 C01EB17 Ivabradine
                  D08095  Ivabradine hydrochloride (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Cardiovascular Agents, Other
               Ivabradine
                D08095  Ivabradine hydrochloride (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D08095  Ivabradine hydrochloride (JAN/USAN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00246  Ivabradine
                 D08095  Ivabradine hydrochloride
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Other ion channels
               Hyperpolarization-activated ion channel
                HCN
                 D08095  Ivabradine hydrochloride (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D08095
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D08095
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D08095
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D08095
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08095
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00246  Ivabradine
DBLINKS     CAS: 148849-67-6
            PubChem: 96024785
            ChEBI: 85969
            LigandBox: D08095
ATOM        35
            1   C8y C    32.4100  -19.5300
            2   C8y C    32.4100  -18.1300
            3   C8x C    31.2200  -17.4300
            4   C8y C    29.9600  -18.1300
            5   C8y C    29.9600  -19.5300
            6   C8x C    31.2200  -20.2300
            7   C1y C    28.5600  -18.1300
            8   C1x C    28.5600  -19.5300
            9   O2a O    33.6000  -20.2300
            10  O2a O    33.6000  -17.4300
            11  C1b C    27.4400  -17.2900
            12  N1c N    26.2500  -17.9900
            13  C1b C    25.0600  -17.2900
            14  C1a C    26.2500  -19.3900
            15  C1a C    34.7900  -18.1300
            16  C1a C    34.7900  -19.5300
            17  C1b C    23.8700  -17.9900
            18  C1b C    22.6800  -17.2900
            19  N1y N    21.4900  -17.9900
            20  C8y C    18.4100  -17.2900
            21  C1x C    19.5300  -16.3800
            22  C5x C    20.8600  -16.7300
            23  C8y C    18.4100  -18.6900
            24  C1x C    20.8600  -19.2500
            25  C1x C    19.5300  -19.5300
            26  O5x O    21.7000  -15.6800
            27  C8x C    17.1500  -16.5900
            28  C8y C    15.9600  -17.2900
            29  C8y C    15.9600  -18.6900
            30  C8x C    17.1500  -19.3900
            31  O2a O    14.7000  -16.5900
            32  C1a C    13.5100  -17.2900
            33  O2a O    14.7000  -19.4600
            34  C1a C    13.5100  -18.7600
            35  X   Cl   26.0400  -13.6500
BOND        37
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     5   8 1
            10    1   9 1
            11    2  10 1
            12    7  11 1 #Down
            13   11  12 1
            14   12  13 1
            15   12  14 1
            16   10  15 1
            17    9  16 1
            18   13  17 1
            19   17  18 1
            20   18  19 1
            21   22  19 1
            22   20  23 1
            23   19  24 1
            24   21  22 1
            25   23  25 1
            26   20  21 1
            27   24  25 1
            28   22  26 2
            29   20  27 2
            30   27  28 1
            31   28  29 2
            32   29  30 1
            33   23  30 2
            34   28  31 1
            35   31  32 1
            36   29  33 1
            37   33  34 1
///
